![Biomunex Pharmaceuticals establishes US subsidiary](https://ala.associates/wp-content/uploads/2022/04/PE-Gerard-e1558960033209-480x250-1.jpg)
![Biomunex Pharmaceuticals establishes US subsidiary](https://ala.associates/wp-content/uploads/2022/04/PE-Gerard-e1558960033209-480x250-1.jpg)
![Microlight3D acquires Smart Force Technologies to add 2D capabilities to its micro-scale 3D-printing systems](https://ala.associates/wp-content/uploads/2022/04/Courtesy-Microlight3D-team-photo-500x250-1.jpg)
Microlight3D acquires Smart Force Technologies to add 2D capabilities to its micro-scale 3D-printing systems
![Minafin launches Minagro, new business unit targeting green and safer ingredients for agribusiness industry](https://ala.associates/wp-content/uploads/2022/04/Minagro-team-500x250-1.jpg)
Minafin launches Minagro, new business unit targeting green and safer ingredients for agribusiness industry
![Medicen Paris Region supports 4 out of 8 healthcare winners in the 2nd edition of the Innovation Challenge](https://ala.associates/wp-content/uploads/2022/04/Medicen-new.png)
Medicen Paris Region supports 4 out of 8 healthcare winners in the 2nd edition of the Innovation Challenge
![Traxens gains confidence of tens of top 500 Beneficial Cargo Owners](https://ala.associates/wp-content/uploads/2022/04/Mockup_image05-500x250-1-1.jpg)
Traxens gains confidence of tens of top 500 Beneficial Cargo Owners
![Minoryx Therapeutics extends its activities in Belgium](https://ala.associates/wp-content/uploads/2022/04/C8I0dRe7-500x250-1.jpeg)
Minoryx Therapeutics extends its activities in Belgium
![20 ans de Genopole : le biocluster veut participer à la constitution de filières pour l’innovation en santé et en environnement](https://ala.associates/wp-content/uploads/2022/04/Grognet-Duval-©Lionel-Antoni-Genopole-500x250-1.jpg)
20 ans de Genopole : le biocluster veut participer à la constitution de filières pour l’innovation en santé et en environnement
![Alizé Pharma 3 moves forward with building a transatlantic biopharmaceutical company focused on rare endocrine and metabolic diseases](https://ala.associates/wp-content/uploads/2022/04/ALZ3-logo.png)
Alizé Pharma 3 moves forward with building a transatlantic biopharmaceutical company focused on rare endocrine and metabolic diseases
![Sofradir elected to Photonics21 Board of Stakeholders](https://ala.associates/wp-content/uploads/2022/04/P.Abraham-flagWEB-500x250-1.jpg)
Sofradir elected to Photonics21 Board of Stakeholders
![Vygon Group acquires 20 per cent of Canadian OxyNov](https://ala.associates/wp-content/uploads/2022/04/oxynov2-500x250-1.png)